Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Zimmer Biomet acquires Compression Therapy Concepts
Zimmer Biomet said last week that it closed its acquisition of Compression Therapy Products for an undisclosed amount.
Eatontown, N.J.-based CTC makes non-invasive devices designed to prevent deep-vein thrombosis. The devices use CTC’s VasoPress system to compress the foot, calf and thigh to lower the risk of pulmonary embolism, according to the company’s website. Read more
4. Report: Boston Scientific to make India its largest OUS hub
Boston Scientific reportedly plans to make a facility in Gurgaon, India, into its largest R&D operation outside the U.S.
“As one of seven strategic global R&D sites for Boston Scientific, the R&D center in India has the potential to be the largest outside of the U.S.,” Prabal Chakraborty, managing director of Marlborough, Mass.-based Boston’s India business, told the Live Mint website. Read more
3. Medtronic touts ‘closed-loop’ insulin management system
In its latest step on the quest to create an artificial pancreas, Medtronic said a pivotal trial showed that its hybrid “closed-loop” insulin management system proved safe and effective. The HCL system is designed to automatically control blood glucose levels with minimal input or supervision from patients or caregivers. The system, using Medtronic’s MiniMed 670G insulin pump, 4th-generation sensors and a control algorithm, was used in a 3-month study of 124 patients with Type I diabetes; 99 subjects opted for a continued-access program after the initial trial ended. Read more
2. Edwards Lifesciences escalates TAVR patent war with Boston Scientific
Edwards Lifesciences last week escalated the patent war with Boston Scientific over transcatheter aortic valve replacements, asking a federal court in Delaware to declare a patent covering the Boston Scientific Lotus TAVR invalid and claiming infringement of a separate patent of its own.
Boston Scientific sued Edwards in the U.S. District Court for Delaware, alleging that the next-generation Sapien 3 valve infringes a patent it acquired along with Sadra Medical for $450 million in 2010. The patent, for an “Everting Heart Valve, covers the Lotus valve. Read more
1. Supreme Court grants Stryker another chance at $228m patent award from Zimmer
The U.S. Supreme Court today ordered an appeals court to reconsider whether the damages should be trebled in Stryker‘s $70 million patent infringement win over Zimmer Biomet, relaxing the standard for enhanced damages awards in patent infringement cases.
The U.S. Court of Appeals for the Federal Circuit in 2014 rolled back the original $228 million verdict, finding that Stryker failed to prove willful infringement. Stryker had sued orthopedics rival Zimmer in December 2010, alleging infringement of 3 patents covering wound debridement technology by Zimmer’s Pulsavac Plus device. Read more
